Mastermind Session: What is the Ideal Radiopharmaceutical Target? Overcoming Biological & Translational Challenges Whilst Expanding the Target Landscape
- Examining lessons from highly expressed targets such as PSMA and somatostatin receptors to inform future target selection
- Investigating strategies for engaging low- to intermediate-density targets with high-potency isotopes such as actinium
- Optimizing radioconjugate design by addressing tumor heterogeneity, target abundance, and molecular format to maximize therapeutic efficacy